High levels of blood glucose and lipids are well-known risk factors for heart diseases. Bee venom is a natural product that has a potent hypoglycemic, hypolipidemic, anti-inflammatory, and antioxidant effects. The current study aimed to determine the bee venom effects on cardiac dysfunction compared to combined therapy of metformin and atorvastatin in diabetic hyperlipidemic rats. The median lethal dose of bee venom was estimated, and then 50 adult male albino rats were categorized into five groups. One group was fed a standard diet and served as a negative control, while the other groups were given nicotinamide and streptozotocin injections to induce type 2 diabetes. After confirming diabetes, the rats were fed a high-fat diet for four weeks. The four groups were divided as follows: one group served as a positive control, whereas the other three groups were treated with bee venom (0.5 mg/kg), bee venom (1.23 mg/kg), and combined therapy of metformin (60 mg/kg) and atorvastatin (10 mg/kg), respectively, for four weeks. Upon termination of the experiment, blood samples and heart tissue were obtained. Administration of bee venom using both doses (0.5 and 1.23 mg/kg) and combined therapy of metformin and atorvastatin revealed a significant decrease in the concentrations of glucose, total cholesterol, triacylglycerol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, troponin I, creatine kinase, and lactate dehydrogenase activities. Moreover, a significant decrease had been detedcted in malondialdehyde, nuclear factor-kappa-β levels, and relative mRNA expression of vascular cell adhesion molecule-1 and galectin-3 in heart tissue compared to the positive control (P < 0.0001). Furthermore, there was a significant increase in bodyweight levels of insulin, high-density lipoprotein cholesterol, and total antioxidant capacity in heart tissue compared to the positive control (P < 0.0001). The results indicate that bee venom can ameliorate cardiac dysfunction through attenuating oxidative stress and downregulating the NF-κβ signaling pathway.
. KernerWBrückelJ.Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes2014;
122:384–6
2.
RawshaniARawshaniAFranzénSSattarNEliassonBSvenssonAMGudbjörnsdottirS.Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med2018;
379:633–44
3.
SolomonSDChewEDuhEJSobrinLSunJKVanderBeekBLGardnerTW.Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care2017;
40:412–8
4.
Al HroobAMAbukhalilMHAlghonmeenRDMahmoudAM.Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy. Biomed Pharmacother2018;
106:381–9
5.
Pop-BusuiRBoultonAJMFeldmanELBrilVFreemanRMalikRAZieglerD.Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care2017;
40:136–54
6.
HanQYeungSCIpMSMMakJC.Dysregulation of cardiac lipid parameters in the high-fat high-cholesterol diet-induced rat model. Lipids Health Dis2018;
17:110
7.
TadicMCuspidiC.Type 2 diabetes mellitus and atrial fibrillation: from mechanisms to clinical practice. Arch Cardiovasc Dis2015;
108:269–76
8.
KhanraRDewanjeeSDuaTKSahuRGangopadhyayMDe FeoVZia-Ul-HaqM.Abroma augusta L.(malvaceae) leaf extract attenuates diabetes-induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. J Transl Med2015;
13:1–14
9.
ShahMSBrownleeM.Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res2016;
118:1808–29
10.
RoudbariLImaniS.The effects of androctonus crassicauda scorpion venom in the treatment of diabetes mellitus type 1 in animal models. Ann Biol Res2012;
3:5782–5
11.
AliM.Studies on bee venom and its medical uses. Int J Adv Res Technol2012;
1:69–83
12.
PuccaMBCerniFAOliveiraISJenkinsTPArgemíLSørensenCVLaustsenAH.Bee updated: current knowledge on bee venom and bee envenoming therapy. Front Immunol2019;
10:1–15
13.
HassanAKEl-KotbyDATawfikMMBadrREBahgatIM.Antidiabetic effect of the egyptian honey bee (Apis mellifera) venom in alloxan-induced diabetic rats. J Basic Appl Zool2019;
80:1–9
14.
CheonSYChungKSRohSSChaYYAnHJ.Bee venom suppresses the differentiation of preadipocytes and high fat diet-induced obesity by inhibiting adipogenesis. Toxins2018;
10:9–23
15.
KimDHSongHS.Atopic dermatitis-related inflammation in macrophages and keratinocytes: the inhibitory effects of bee venom. J Acupunct Res2019;
36:80–7
16.
ParkHGLeeKSKimBYYoonHJChoiYSLeeKYJinBR.Honeybee (Apis cerana) vitellogenin acts as an antimicrobial and antioxidant agent in the body and venom. Dev Comp Immunol2018;
85:51–60
17.
KangGHLeeSChoiDBShinDKimJYangHBaeH.Bee venom phospholipase A2 ameliorates atherosclerosis by modulating regulatory T cells. Toxins2020;
12:609–21
18.
ReedLJMuenchH.A simple method of estimating 50 per cent end points. Am J Hyg1938;
27:493–7
19.
ReevesPGNielsenFHFahey JrGC.AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr1993;
123:1939–51
20.
YuanYLiuQZhaoFCaoJShenXLiC.Holothuria leucospilota polysaccharides ameliorate hyperlipidemia in high-fat diet-induced rats via short-chain fatty acids production and lipid metabolism regulation. Int J Mol Sci2019;
20:4738–51
21.
PunithaIRRajendranKShirwaikarAShirwaikarA.Alcoholic stem extract of coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin–nicotinamide induced diabetic rats. Evid Based Complement Alternat Med2005;
2:375–81
22.
DeedsMCAndersonJMArmstrongASGastineauDAHiddingaHJJahangirAKudvaYC.Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim2011;
45:131–40
23.
KumarMDandapatSSinhaMPKumarARaipatBS.Different blood collection methods from rats: a review. Balneo Res J2017;
8:46–50
24.
SunderASReddyARNKiranGThirumuruguS.Antihyperlipidemic and antioxidant activity of methanolic extract of trianthema portulacastrum in rats fed a high-fat diet. J Herbs Spices Med Plants2010;
16:193–202
25.
MousaviSMImaniSHaghighiSMousaviSEKarimiA.Effect of iranian honey bee (Apis mellifera) venom on blood glucose and insulin in diabetic rats. J Arthropod Borne Dis2012;
6:136–43
26.
PhatakRSKhanwelkarCCMatuleSMDatkhileKHendreA.Antihyperglycemic activity of murraya koenigii leaves extract on blood sugar level in streptozotocin-nicotinamide induced diabetes in rats. Biomed Pharmacol J2019;
12:597–602
27.
MatafomePLouroTRodriguesLCrisostomoJNunesEAmaralCSeicaR.Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes Metab Res Rev2011;
27:54–62
28.
ThavasuPWLonghurstSJoelSPSlevinMLBalkwillFR.Measuring cytokine levels in blood. Importance of anti-coagulants, processing, and storage conditions. J Immunol Methods1992;
153:115–24
29.
BadawySMHammadSAAmineSAEl-SeidyAMSlimaSRA.Biochemical and histopathological changes in the brain of albino rats treated with profenofos and the possible protective effect of vitamins C and E. Menoufia Med J2017;
30:278–85
30.
VaughtJBHendersonMK.Biological sample collection, processing, storage and information management. IARC Sci Publ2011;
163:23–42
31.
PanigrahySKKumarABhattR.In vitro and in vivo anti-diabetic activity of fractions obtained from the unexplored hedychium coronarium rhizome. Proc Natl Acad Sci India Sect B2019;
90:605–14
32.
MorganCRLazarowA.Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes1963;
12:115–26
33.
SteinEAMyersGL.Lipids, lipoproteins and apolipoproteins. Fundam Clin Chem1987;
3:478–9
34.
YoungDSFriedmanRBNgV.Effects of disease on clinical laboratory tests, vol. 1 and 2. Clin Chem2002;
48:682–3
35.
WarnickGRWoodPD.National cholesterol education program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. The national cholesterol education program working group on lipoprotein measurement. Clin Chem1995;
41:1427–33
36.
FriedewaldWTLevyRIFredricksonDS.Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem1972;
18:499–502
37.
NorbertWT.Clinical guide to laboratory tests. 3rd ed.Philadelphia:
Saunders W.B. Company, 1995, pp. 268–73.
38.
WuAHBowers JrGN.Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals. Clin Chem1982;
28:2017–21
39.
BergmeyerHU.Methods of enzymatic analysis. Vol.
42.
New York:
Academic, 1974, pp.321–7.
40.
KiyasuY.Current status of detecting Troponin-I for patient management. Am Clin Prod Rev1985;
4:29–31
41.
KoracevicDKoracevicGDjordjevicVAndrejevicSCosicV.Method for the measurement of antioxidant activity in human fluids. J Clin Pathol2001;
54:356–61
42.
SatohK.Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta1978;
90:37–43
43.
HeppnerCBilimoriaKYAgarwalSKKesterMWhittyLJGuruSCBurnsAL.The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene2001;
20:4917–25
44.
LivakKJSchmittgenTD.Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods2001;
25:402–8
45.
BancroftJDGambleM.Theory and practice of histological techniques. 6th ed.London:
Elsevier health Sciences, 2008, pp.83–134.
46.
ValentinJFrobertAAjalbertGCookSGiraudMN.Histological quantification of chronic myocardial infarct in rats. J Visual Exp2016;
118:1–8
47.
Abu-BaderSH.Using statistical methods in social science research: with a complete SPSS guide. 3rd ed.Oxford:
Oxford University Press, 2021, pp.297–302.
48.
SarwarNGaoPSeshasaiSRGobinRKaptogeSDi AngelantonioEDaneshJ.Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative Meta-analysis of 102 prospective studies. Lancet2010;
375:2215–22
49.
BorenJChapmanMJKraussRMPackardCJBentzonJFBinderCJGinsbergHN.Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J2020;
41:2313–30
50.
WehbeRFrangiehJRimaMEl ObeidDSabatierJMFajlounZ.Bee venom: overview of main compounds and bioactivities for therapeutic interests. Molecules2019;
24:2997–3009
51.
de SouzaJMGoncalvesBDCGomezMVVieiraLBRibeiroFM.Animal toxins as therapeutic tools to treat neurodegenerative diseases. Front Pharmacol2018;
9:1–25
52.
RaafatMHamamGG.The possible role of bee venom on gastric fundic mucosa in streptozotocin induced diabetes mellitus in rats. A histological study. Egypt J Histol2020;
42:1029–43
53.
ZidanH-GMostafaZKIbrahimMAHaggagSIDarwishDAElfikyAA.Venom composition of Egyptian and Carniolan honeybee, Apis mellifera L. Affected by collection methods. Egypt Acad J Biol Sci A Entomol2018;
11:59–71
54.
KimY-JLimC-SKwonK-R.Study of single dose test of sweet bee venom in rats. J Pharmacopuncture2009;
12:5–32
55.
QuistadGBSkinnerWSSchooleyDA.Venoms of social hymenoptera – toxicity to the lepidopteran, manduca sexta. Insect Biochem1988;
18:511–4
56.
HabermannE.Bee and wasp venoms. Science1972;
177:314–22
57.
DeviASangeetaNRKaurJ.Honey bee venom and its composition: focusing on different apis species – a review. World2016;
68:51–71
58.
Farshineh AdlMBGençerHVFiratliÇBahreiniR.Morphometric characterization of iranian (Apis mellifera meda), Central anatolian (Apis mellifera anatoliaca) and caucasian (Apis mellifera caucasica) honey bee populations. J Apic Res2007;
46:225–31
59.
RochaDSCasagrandeLModelJFAdos SantosJTHoefelALKucharskiLC.Effect of yerba mate (ilex paraguariensis) extract on the metabolism of diabetic rats. Biomed Pharmacother2018;
105:370–6
60.
Al-AwaidaWJSharabASAl-AmeerHJAyoubNY.Effect of simulated microgravity on the antidiabetic properties of wheatgrass (Triticum aestivum) in streptozotocin-induced diabetic rats. npj Microgravity2020;
6:1–10
61.
Al-EnaziMM.Combined therapy of rutin and silymarin has more protective effects on streptozotocin-induced oxidative stress in rats. J Appl Pharm Sci2014;
4:21–8
62.
KumarRAroraVRamVBhandariAVyasP.Hypoglycemic and hypolipidemic effect of allopolyherbal formulations in streptozotocin induced diabetes mellitus in rats. Int J Diabetes Mellit2015;
3:45–50
63.
AsokanSMWangR-YHungT-HLinWT.Hepato-protective effects of glossogyne tenuifolia in streptozotocin-nicotinamide-induced diabetic rats on high fat diet. BMC Complement Altern Med2019;
19:1–10
64.
ParkHJLeeHJChoiMSSonDJSongHSSongMJHongJT.JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J Inflamm2008;
5:1–13
65.
SimonssonEKarlssonSAhrénB.Islet phospholipase A2 activation is potentiated in insulin resistant mice. Biochem Biophys Res Commun2000;
272:539–43
66.
BadrGHozzeinWNBadrBMAl GhamdiASaad EldienHMGarraudO.Bee venom accelerates wound healing in diabetic mice by suppressing activating transcription factor‐3 (ATF‐3) and inducible nitric oxide synthase (iNOS)‐mediated oxidative stress and recruiting bone marrow‐derived endothelial progenitor cells. J Cell Physiol2016;
231:2159–71
67.
MorganNGMontagueW.Stimulation of insulin secretion from isolated rat islets of langerhans by melittin. Biosci Rep1984;
4:665–71
68.
ElberryAAHarrazFMGhareibSAGabrSANagyAAAbdel-SattarE.Methanolic extract of marrubium vulgare ameliorates hyperglycemia and dyslipidemia in streptozotocin-induced diabetic rats. Int J Diabetes Mellit2015;
3:37–44
69.
AdekunleASAdedejiALOyewoEOAdedosuOTOmotosoAT.Hyperlipidemia induced by atherogenic diet enhanced oxidative stress in the kidney and inflammatory responses: an in-vivo study. Asian J Nat Appl Sci2013;
2:82–93
70.
WangXGaoLLinHSongJWangJYinYLiL.Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli. Eur J Pharmacol2018;
824:170–8
71.
VengalaN.Antihyperlipidemic activity of flax lignan concentrate in nicotinamide-streptozotocin induced diabetic hyperlipidemia rats. Res Rev Biosci2017;
12:120–33
72.
ElseweidyMMAlySIHammadSKShershirNI.Early myocardial injury biomarkers in diabetic hyperlipidemic rats: impact of 10-dehydrogingerdione and vitamin D3. Exp Biol Med2020;
245:1326–34
73.
KhulanTSAmbagaMChimedragchaCH.Effect of honey bee venom (Apis mellifera) on hyperglycemia and hyperlipidemia in alloxan induced diabetic rabbits. J Diabetes Metab2015;
6:3–6
74.
HanafiMYZaherELMEl-AdelySEMSakrAGhobashiAHHemlyMHKamelMA.The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats. Exp Ther Med2018;
15:5091–9
75.
SinghJRanganathanR.Quantitation of lysolipids, fatty acids, and phospholipase A2 activity and correlation with membrane polarity. J Lipid Res2012;
53:1993–2001
76.
González-MonteroJBritoRGajardoAIJRodrigoR.Myocardial reperfusion injury and oxidative stress: therapeutic opportunities. World J Cardiol2018;
10:74–86
77.
Pranav NayakBGaneshaKRMinazNRazdanRGoswamiSK.Phloroglucinol, a nutraceutical for IR‐induced cardiac damage in diabetic rats. Animal Model Exp Med2019;
2:210–6
78.
QiuZMingHZhangYYuYLeiSXiaZY.The protective role of Bmal1-Regulated autophagy mediated by HDAC3/SIRT1 pathway in myocardial ischemia/reperfusion injury of diabetic rats. Cardiovasc Drugs Ther2021;
35:1–15
79.
ShaabanAMMHamzaRG.Studying the ameliorative effect of bee venom against damage and inflammation induced in gamma-irradiated rats. Arab J Nucl Sci Appl2019;
52:178–84
80.
SobralFSampaioAFalcãoSQueirozMJRCalhelhaRCVilas-BoasMFerreiraIC.Chemical characterization, antioxidant, anti-inflammatory and cytotoxic properties of bee venom collected in northeast Portugal. Food Chem Toxicol2016;
94:172–7
81.
SafhiMMAnwerTKhanGSiddiquiRSivakumarSMAlamMF.The combination of canagliflozin and omega-3 fatty acid ameliorates insulin resistance and cardiac biomarkers via modulation of inflammatory cytokines in type 2 diabetic rats. Korean J Physiol Pharmacol2018;
22:493–501
82.
ThakurVAlcorezaNDelgadoMJoddarBChattopadhyayM.Cardioprotective effect of glycyrrhizin on myocardial remodeling in diabetic rats. Biomolecules2021;
11:569–83
83.
HisalkarPJPatneABFawadeMM.Assessment of plasma antioxidant levels in type 2 diabetes patients. Int J Biol Med Res2012;
3:1796–800
84.
RahimiRKarimiJKhodadadiITayebiniaHKheiripourNHashemniaMGoliF.Silymarin ameliorates expression of urotensin II (U-II) and its receptor (UTR) and attenuates toxic oxidative stress in the heart of rats with type 2 diabetes. Biomed Pharmacother2018;
101:244–50
85.
TripathiPVermaMKTripathiSSSinghSP.Comparative study of malondialdehyde and vitamin C in type 2 diabetes mellitus and non diabetic individuals. Int J Life Sci Sci Res2016;
2:9–14
86.
PektaşAPektaşMBKocaHBTosunMAslanEKocaSSadiG.Effects of resveratrol on diabetes-induced vascular tissue damage and inflammation in male rats. Turkish J Biochem2017;
42:451–8
87.
JiaGHillMASowersJR.Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res2018;
122:624–38
88.
YuanTYangTChenHFuDHuYWangJXieX.New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol2019;
20:247–60
89.
KumarSPrasadSSitasawadSL.Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats. PLoS One2013;
8:1–12
90.
ALTamimiJZBinMowynaMNAlFarisNAAlagalRIEl-KottAFAl-FargaAM.Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R. Saudi Pharm J2021;
29:27–42
91.
KimW-HAnH-JKimJ-YGwonMGGuHParkJBParkKK.Bee venom inhibits porphyromonas gingivalis lipopolysaccharides-induced pro-inflammatory cytokines through suppression of NF-κB and AP-1 signaling pathways. Molecules2016;
21:1508–23
92.
ThayseKKindtNLaurentSCarlierS.VCAM-1 target in non-invasive imaging for the detection of atherosclerotic plaques. Biology2020;
9:368–89
93.
GraysonMHVan der VierenMSterbinskySAMichael GallatinWHoffmanPAStauntonDEBochnerBS.αdβ2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1). J Exp Med1998;
188:2187–91
94.
RaoSPWangZZuberiRISikoraLBahaieNSZurawBLSriramaraoP.Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow. J Immunol2007;
179:7800–7
95.
CybulskyMIIiyamaKLiHZhuSChenMIiyamaMMilstoneDS.A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest2001;
107:1255–62
96.
YinYXuYMaHTianX. Hesperetin ameliorates cardiac inflammation and cardiac fibrosis in streptozotocin-induced diabetic rats by inhibiting NF-kB signaling pathway. Biomed Res 2017;28:223–9
97.
LeeWRKimSJParkJHKimKHChangYCParkYYParkKK.Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism. Am J Chin Med2010;
38:1077–92
98.
WeigertJNeumeierMWanningerJBauerSFarkasSSchererMNBuechlerC.Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endocrinol Metab2010;
95:1404–11
99.
SonkawadeSDSuzukiGXuSKcKPokharelSSharmaUC.Cardioselective galectin-3 overexpression in mice activates MAPK/ERK1/2 signaling and induces myocardial fibrosis. Circulation2019;
140:A12548
100.
SalemAMMahdyKAHassanNSEl-SaeedGSFarragARHMonemMAA.Nigella sativa seed reduced galectin-3 level and liver fibrosis in thioacetamide-induced liver injury in rats. J Arab Soc Med Res2017;
12:46–55
101.
ThandavarayanRAWatanabeKMaMVeeraveeduPTGurusamyNPalaniyandiSSAizawaY.14-3-3 Protein regulates Ask1 signaling and protects against diabetic cardiomyopathy. Biochem Pharmacol2008;
75:1797–806
102.
Marín-RoyoGGallardoIMartínez-MartínezEGutiérrezBJurado-LópezRLópez-AndrésNCachofeiroV.Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity. Dis Model Mech2018;
11:1–9
AlshabiAMAlkahtaniSAShaikhIHabeebMS.Caffeine modulates pharmacokinetic and pharmacodynamic profiles of pioglitazone in diabetic rats: impact on therapeutics. Saudi Med J2021;
42:151–60
105.
SalehNKSalehHA.Cardiac effects of bee venom in rats. Saudi Med J2011;
32:563–70
106.
SunYHanMShenZHuangHMiaoX.Anti-hypertensive and cardioprotective effects of a novel apitherapy formulation via upregulation of peroxisome proliferator-activated receptor-α and-γ in spontaneous hypertensive rats. Saudi J Biol Sci2018;
25:213–9
